Logo-jre

   
J Ren Endocrinol. 2022;8: e21062 | Published on: 2022 Oct 22. doi: 10.34172/jre.2022.21062

Original Article

Assessment the efficacy and safety of denosumab use for treatment of osteoporosis in hemodialysis patients

Bassam Al-Helal 1 ORCID, Emad Abdallah 1 * ORCID, Reem Asad 1 ORCID, Mohamed Kassab 2, Anas Al Yousef 2, George Nessim 1, Ahmed Radi 2, Mohamed Mostafa 2, Yasser Elsharkawi 1, Esam Allam 1, Ahmed Elmasry 1, Mohamed Hemida 1, Mohamed Abdelgelil 1, Sahar Abdelkareem 1, Mohammad Kamal 1, Amr Saad 1, Shaikha Al-Bader 1, Rania Tharwat 1, Yasser Shaaban 1, Mahmoud Reda 1, Abuhashem Ahmed 1, Nadeen Abdelhaleem 1, Zeinab Zeid 1

Cited by CrossRef: 0

1- Rizi M, Salari A, Salesi M, Rasooli L, Karimifar M. Comparison of bone mineral density of osteoporotic and osteopenia menopausal women treated with oral bisphosphonates before stopping the treatment and 1 year after drug holiday period. Clin Rheumatol. 2024;43(4):1375 [Crossref]